HighCost Drugs Challenges and Opportunities June 15 2015 Logistics To join the session by phone only please call the number below and enter the access code US Toll Free 18557979485 Access ID: 531231
Download Presentation The PPT/PDF document "ACHP Live Interview" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
ACHP Live Interview
High-Cost Drugs: Challenges and Opportunities
June 15, 2015Slide2
Logistics
To join the session by phone only, please call the number below and enter the access code.
US Toll Free: 1-855-797-9485
Access
Code: 647 421
659
If you experience
issues
with audio during today’s
discussion, please:
Inform Jennifer Sulkin via the WebEx chat function or contact ACHP at 202-785-2245 if issues persist.
When submitting questions, we ask that you use the
CHAT
function and direct your questions to the
HOST
.
All participants have been placed on mute upon entry. Please DO NOT place your phones on hold being this may cause interruptions.
A recording of today’s discussion and the slide presentation will be available on ACHP’s website. Visit
www.achp.org
for more information.Slide3
Kavita Patel, M.D., M.S.
Fellow and Managing Director
,
Brookings Institution Center for Health Policy
Dr. Patel is a Fellow and Managing Director at the Center for Health Policy at the Brookings Institution where she leads research on delivery system reforms, healthcare cost, physician payment and healthcare workforce productivity. Additionally, Dr. Patel is a practicing primary care physician at Johns Hopkins Medicine and a clinical instructor at UCLA's Geffen School of Medicine. Dr. Patel was previously a Director of Policy for The White House under President Obama and a senior advisor to the late Senator Edward Kennedy. Her prior research in healthcare quality and community approaches to mental illness have earned national recognition and she has published numerous papers and book chapters on healthcare reform and health policy. She has testified before Congress several times and she is a frequent guest expert on CBS, NBC and MSNBC as well as serving on the editorial board of the journal Health Affairs.Dr. Patel can be reached at KPatel@brookings.edu. Slide4
Ceci Connolly
Managing
Director,
PwC’s
Health Research InstituteCeci Connolly is the Managing Director of the Health Research Institute at PricewaterhouseCoopers, a research organization dedicated to objective analysis on the issues, policies and trends important to health organizations and policymakers.
She
is a veteran journalist, and as the national health correspondent for the Washington Post, chronicled enactment of the Affordable Care Act and was co-author of
Landmark: The Inside Story of America’s New Health Care Law and What It Means for Us All.
In
her role at the Health Research Institute, Connolly oversees a team of analysts and writers who track major developments and emerging issues across the healthcare spectrum.
Ceci can
be reached at
ceci.connolly@us.pwc.com
. Slide5
Leslie
Fish, Pharm.D.
Vice
President of Clinical Programs, Fallon Health
Dr. Fish is the Vice President of Clinical Programs at Fallon Health and has more than 25 years of experience in the health care field as a practicing pharmacist with particular expertise in oncology and cardiology, a consultant, educator, researcher and writer. She is on the faculty of the John Meyers Primary Care Institute Managed Care Residency Program and has taught at the University of Massachusetts Medical School, Massachusetts College of Pharmacy and Allied Health Sciences and Northeastern University School of Pharmacy, Boston. She has served on the editorial board of several journals and is an active member of the Academy of Managed Care Pharmacy where she serves on the Professional Practice Committee. Dr. Fish is on the state’s Drug Utilization Review board in Massachusetts
and has
been recognized for her work as the winner of the National Osteoporosis Award (1997), Innovations in Pharmacy Award (1999) and the American Medical Group
Association’s
Acclaim Award (2001).
Dr. Fish can be reached at
leslie.fish@fchp.org
. Slide6
Eileen
Wood
,
R.Ph., M.B.A.Vice President of Clinical Integration and Chief Pharmacy Officer,
Capital District Physicians’ Health PlanEileen Wood has more than 30 years of experience as a pharmacist and health care industry leader. Eileen joined CDPHP in 2005 and is responsible for the pharmacy benefit, clinical pharmacy programs, health care performance management, and quality management teams. Prior to joining CDPHP, Eileen served as vice president of clinical services and director of pharmacy services for Seton Health System in Troy, NY, part of the Ascension Health System. Eileen began her career in an independent community pharmacy practice, and her experience includes progressive hospital pharmacy and management experience in oncology, surgery, laboratory, cardio-pulmonary, medical imaging, and other clinical services management. Eileen can be reached at
Eileen.Wood@cdphp.com
. Slide7
ACHP Live Interview
High-Cost Drugs: Challenges and Opportunities
June 15, 2015Slide8
ACHP
High-Cost Drugs: Challenges and Opportunities
Ceci Connolly
Managing Director, PwC’s HRI
June 15th, 2015Slide9
Why are specialty drugs costs becoming a big issue?
361% growth
Source: PwC’s Health Research Institute: Behind the Numbers 2015 and analysis of CVS Caremark data.
Only
4% of patients use specialty drugs, but those drugs account for 25% of total US drug
spending.
One
specialty drug
costs more than a company's annual drug spending
budget.
The difference in price between two therapies was approximately 4000 times the cost of gold!
–
D
r. L.
Saltz
, colorectal oncology, Memorial Sloan Kettering Cancer CenterSlide10
Specialty drug approvals continue to race ahead
–
Source: PwC Health Research Institute research based on data from the FDA, Express Scripts, Catamaran, and Thomson ReutersSlide11
Physician reimbursement
Mortgaging drug costs
Improving transparency
Paying for drugs requires new finance models
Exclusivity on ROS
Outcomes based contracts
Reforming Medicaid’s Best Price
Reference pricing
Ceiling price
Alternative modelsSlide12
Panelists
12
Kavita Patel,
M.D.
(Moderator)
Ceci
Connolly
Leslie Fish,
Pharm.D
.
Eileen Wood,
R.Ph
., M.B.A.Slide13
QUESTIONS?
REMINDER: When
submitting
questions we
ask that you use the CHAT function and direct your questions to the HOST.Slide14
Phone: 202-785-2247
Fax: 202-785-4060
www.achp.org
1825 Eye Street,
NWSuite
401
Washington, DC 20006
THANK YOU